# NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event

Study · id `cardio:ct-nct01578629` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01578629](<https://clinicaltrials.gov/study/NCT01578629>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01578629

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

## Technical summary

Registry record NCT01578629. Randomized; double masking; primary purpose health services research. Start 2012-03 (registry gives no type); primary completion 2018-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose health services research
- Phase: Phase 1/2
- Enrolled: 210 participants (enrolled count; ClinicalTrials.gov record NCT01578629, source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)
- Start date: 2012-03 (registry gives no type) (ClinicalTrials.gov record NCT01578629, source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)
- Primary completion: 2018-11 (actual) (ClinicalTrials.gov record NCT01578629, source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT01578629, source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01578629, source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01578629-2021-09-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event
- Acronym: NUTRITION
- Condition: Ischemic Stroke
- Condition: Transient Ischemic Attack (TIA)
- Intervention (Other): Vitamin E tocotrienol (TCT) capsules ; Low dose Aspirin
- Intervention (Other): Placebo vehicle control
- Lead sponsor: Andrew Slivka
- Lead sponsor class: OTHER
- Collaborator: Government of Malaysia
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: d6fbc149e7a75f337dea8a441e00577adcca9aecf726c4478e54e3212d903d65
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
